Engineers Gate Manager’s Revolution Medicines RVMD Stock Holding History

Engineers Gate Manager’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Buy	7,380 +4,356	+144%	+$636K	0.02%	896
2026 Q1	$294K	Sell	3,024 -10,432	-78%	-$1.05M	﹤0.01%	1716
2025 Q4	$1.07M	Sell	13,456 -16,936	-56%	-$1.11M	0.01%	997
2025 Q3	$1.42M	Sell	30,392 -17,133	-36%	-$671K	0.02%	966
2025 Q2	$1.75M	Buy	+47,525	New	+$1.83M	0.02%	796
2024 Q3	–	Sell	-46,159	Closed	-$1.79M	–	2365
2024 Q2	$1.79M	Buy	46,159 +34,951	+312%	+$1.31M	0.04%	605
2024 Q1	$361K	Buy	+11,208	New	+$332K	0.01%	1369
2023 Q4	–	Sell	-54,082	Closed	-$1.5M	–	2208
2023 Q3	$1.5M	Buy	+54,082	New	+$1.6M	0.06%	492
2023 Q2	–	Sell	-28,452	Closed	-$616K	–	1991
2023 Q1	$616K	Buy	+28,452	New	+$701K	0.03%	872
2021 Q3	–	Sell	-18,099	Closed	-$574K	–	1932
2021 Q2	$574K	Buy	+18,099	New	+$632K	0.04%	753

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Engineers Gate Manager's RVMD Position: Q2 2026 in Review

Engineers Gate Manager increased its Revolution Medicines (RVMD) stake by 144% in Q2 2026, buying an estimated $636K and bringing the position to 7,380 shares worth $1.38M. The position accounts for 0.02% of the portfolio, ranked #896.

Engineers Gate Manager first reported a position in RVMD in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.79M in Q2 2024. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Engineers Gate Manager held 7,380 shares of Revolution Medicines worth $1.38M as of Q2 2026.
Engineers Gate Manager bought 4,356 Revolution Medicines shares in Q2 2026, an estimated $636K.
Revolution Medicines made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #896 holding.
Engineers Gate Manager first reported a position in Revolution Medicines in Q2 2021 and has held it in 10 quarters since.
Engineers Gate Manager's Revolution Medicines position peaked at $1.79M in Q2 2024.
690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.